Neolife Pharmaceuticals Private Limited
About Neolife Pharmaceuticals Private Limited
Data last updated:
Neolife Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2019PTC129480. Its GSTIN is 36AAGCN3461K1Z8 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sujatha Bestha and Shravanthi Thinderu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.12 – 1 – 361 Flat No.101 Pasthams Sai Krishna Residency Indraprasta Colony, Hyderabad, Telangana, India – 500068.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.07 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹5.07 Lakh (net margin 4.7%) and EBITDA of ₹7.01 Lakh (EBITDA margin 6.5%).
As per MCA filings, the company has open charges of ₹41.28 Lakh on record.
Company details
Contact details
Neolife Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.12 – 1 – 361 Flat No.101 Pasthams Sai Krishna Residency Indraprasta Colony, Hyderabad, Telangana, India – 500068
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Neolife Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Neolife Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Neolife Pharmaceuticals Private Limited, buy the company report.
Financials of Neolife Pharmaceuticals Private Limited
FY 2025 filings availableNeolife Pharmaceuticals Private Limited reported revenue of ₹1.07 Cr (up 57% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 57% in the latest year. EBITDA rose 35% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.07 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.07 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neolife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neolife Pharmaceuticals Private Limited
Neolife Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sujatha Bestha | Director | 03 Jan 2019 | 7 Years 10 Months | Current |
| Shravanthi Thinderu | Director | 06 Mar 2023 | 3 Years 8 Months | Current |
Peer comparison
Neolife Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Insutik Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | -6.0% | Bareilly, Uttar Pradesh, India | |||
| Neolife Pharmaceuticals Private Limitedthis company | ₹1.07 Cr (FY 2023) | ₹5.07 Lakh | 4.7% | 57.0% | Hyderabad, Telangana, India | |
| Oswald Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | 80.0% | Bangalore, Karnataka, India | |||
| Parkem Pharmaceuticals Private Limited | ₹1.07 Cr (FY 2025) | -3.0% | Ranchi, Jharkhand, India |
To see the full peer comparison of Neolife Pharmaceuticals Private Limited, buy the company report.
Auditor
Neolife Pharmaceuticals Private Limited is audited by KOTI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOTI & CO | FY 2023 | 242066 |
Shareholding
The shareholding of Neolife Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Neolife Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2025 | 101119786 | Hdfc Bank Limited | ₹16.28 Lakh | Open | |
| 28 Mar 2025 | 101099368 | State Bank of India | ₹25 Lakh | Open |
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Neolife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neolife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neolife Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCN3461K1Z8 | Telangana | Active | 01 Oct 2021 |
To see the full GST registrations and return filing status of Neolife Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neolife Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Gunukula Suresh Reddy ceased to be Director on 06 Mar 2023.
Frequently asked questions
Neolife Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 January 2019 (7+ years old) and is registered under CIN U24100TG2019PTC129480.
Neolife Pharmaceuticals has 2 current directors:
- Sujatha Bestha - Director
- Shravanthi Thinderu - Director
The latest financial statements of Neolife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Neolife Pharmaceuticals is 36AAGCN3461K1Z8, registered in Telangana.
The CIN (Corporate Identification Number) of Neolife Pharmaceuticals is U24100TG2019PTC129480. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neolife Pharmaceuticals was incorporated on 03 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Neolife Pharmaceuticals by revenue are Insutik Pharmaceuticals Private Limited, Oswald Pharmaceuticals Private Limited, Parkem Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gunukula Suresh Reddy ceased to be Director on 06 Mar 2023. Shravanthi Thinderu was appointed as Director on 06 Mar 2023. Sumathi Nalipireddy ceased to be Director on 15 Dec 2022. Neolife Pharmaceuticals has 5 board changes on record in total.
The registered office of Neolife Pharmaceuticals is at H.No.12 – 1 – 361 Flat No.101 Pasthams Sai Krishna Residency Indraprasta Colony, Hyderabad, Telangana, India – 500068.
Neolife Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Neolife Pharmaceuticals has open charges of ₹41.28 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
